Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FXLV6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,333
Award facts
- Contract value 100% obligated
- $25,332.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $25,332.96 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Ocrevus, a specialty biologic medication used primarily in the treatment of multiple sclerosis, represents the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements through open competition, ranging from routine pharmaceutical deliveries to complex specialty medications supporting military and veteran healthcare needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FXLV6?
SPE2DR26FXLV6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FXLV6 worth?
The government has obligated $25,333 on SPE2DR26FXLV6.
Is contract SPE2DR26FXLV6 an order under another contract?
Yes. SPE2DR26FXLV6 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXLV6 competed?
The extent of competition for SPE2DR26FXLV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award